The Lancet Regional Health. Western Pacific (Oct 2023)
Towards elimination of cervical cancer – human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countriesSearch strategy and selection criteria
- Sok King Ong,
- Sarah K. Abe,
- Shyamala Thilagaratnam,
- Rei Haruyama,
- Ruchi Pathak,
- Harindra Jayasekara,
- Kayo Togawa,
- Aliza K.C. Bhandari,
- Abhishek Shankar,
- Ashrafun Nessa,
- Uranbolor Jugder,
- Julyanti Agustina,
- Mohammed Biglari,
- Aasim Yusuf,
- Ugyen Tshomo,
- Eshani Fernando,
- Clarito Cairo,
- Kyaw Kan Kaung,
- Beauta Rath,
- Champadeng Vongdala,
- Kishore Kumar Pradhananga,
- Jeongseon Kim,
- Youn Kyung Chung,
- Tran Thi Thanh Huong,
- Suleeporn Sangrajran,
- Yawei Zhang,
- Partha Basu,
- Yin Ling Woo,
- Babu Sukumaran,
- William Y.K. Hwang
Affiliations
- Sok King Ong
- PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Brunei Darussalam; Corresponding author.
- Sarah K. Abe
- National Cancer Center Institute for Cancer Control, Tokyo, Japan
- Shyamala Thilagaratnam
- Health Promotion Board, Singapore
- Rei Haruyama
- Bureau of International Health Cooperation, National Center for Global Health and Medicine, Japan
- Ruchi Pathak
- Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, India
- Harindra Jayasekara
- Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia
- Kayo Togawa
- National Cancer Center Institute for Cancer Control, Tokyo, Japan
- Aliza K.C. Bhandari
- National Cancer Center Institute for Cancer Control, Tokyo, Japan
- Abhishek Shankar
- Department of Radiation Oncology, Dr B R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, Delhi, India
- Ashrafun Nessa
- Department of Gynaecological Oncology, Bangabandhu Sheikh Mujib Medical University, Bangladesh
- Uranbolor Jugder
- Cancer Registry-surveillance and Early Detection Division, National Cancer Center of Mongolia, Ulaanbaatar, Mongolia
- Julyanti Agustina
- National Cancer Center Indonesia, Dharmais Cancer Hospital, Jakarta, Indonesia
- Mohammed Biglari
- Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran
- Aasim Yusuf
- Shaukat Khanum Memorial Cancer Hospital and Research Centres, Lahore and Peshawar, Pakistan
- Ugyen Tshomo
- Jigme Dorji Wangchuck National Referral Hospital, Bhutan
- Eshani Fernando
- National Cancer Control Programme, Ministry of Health, Sri Lanka
- Clarito Cairo
- Department of Health, Disease Prevention and Control Bureau, Manila, Philippines
- Kyaw Kan Kaung
- Department of Public Health, Ministry of Health, Naypyidaw, Myanmar
- Beauta Rath
- Calmette Hospital, Phnom Penh, Cambodia
- Champadeng Vongdala
- Cancer Center, Mittaphab Hospital, Vientiane, Lao PDR
- Kishore Kumar Pradhananga
- Kathmandu Cancer Center Hospital, Tathali, Bhaktapur, Nepal
- Jeongseon Kim
- National Cancer Center Korea, Goyang, Republic of Korea
- Youn Kyung Chung
- National Cancer Center Korea, Goyang, Republic of Korea
- Tran Thi Thanh Huong
- Vietnam National Cancer Institute & Hanoi Medical University, Hanoi, Vietnam
- Suleeporn Sangrajran
- National Cancer Institute, Bangkok, Thailand
- Yawei Zhang
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
- Partha Basu
- International Agency for Research on Cancer (IARC/WHO), Lyon, France
- Yin Ling Woo
- University of Malaya & ROSE Foundation, Kuala Lumpur, Malaysia
- Babu Sukumaran
- The Brunei Cancer Center, PJSC, Brunei Darussalam
- William Y.K. Hwang
- National Cancer Centre & Duke-NUS Medical School, Singapore
- Journal volume & issue
-
Vol. 39
p. 100860
Abstract
Summary: About 95% of cervical cancers worldwide are caused by human papillomavirus (HPV). Cervical cancer is preventable and curable if it is detected and treated early. We reviewed the latest national cervical cancer indicators, and barriers to HPV vaccination and cervical cancer screening in 21 Asian National Cancer Centers Alliance (ANCCA) member countries. Half (n = 11, 52%) of the countries have introduced HPV vaccination for girls as part of their national vaccination programme, three countries reported coverage of over 90%. Most ANCCA member countries have cervical cancer screening programmes, only five countries reported screening uptake of over 50%. The barriers to HPV vaccination coverage and cervical cancer screening participation have been identified. Ensuring health service accessibility and affordability for women, addressing sociocultural barriers, and strengthening the healthcare system and continuum of care are essential to increase HPV vaccination and cervical cancer screening coverage.
